Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02737501
Brief Title: ALTA-1L Study: A Phase 3 Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants (ALTA-1L)

First Submitted : March 30, 2016
First Submitted that Met QC Criteria : April 11, 2016
First Posted : April 14, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : December 21, 2020
Last Update Posted : December 23, 2020